NaturoMed Therapeutics, the parent company of Stay Wyld Organics, is a vertically integrated functional and medicinal mushroom company. NaturoMed Therapeutics is currently producing bulk functional mushroom powders at its state of the art facility in BC, Canada and selling functional mushroom products to the retail market throughout North America. The company is committed to improving global mental and physical health through the production and distribution of high-quality Canadian grown organic mushroom products. NaturoMed is excited to announce that construction is well underway for its Health Canada Controlled Substances Dealer’s License to produce Psilocybin. Estimated completion is Q4, 2022. NaturoMed plans to produce Psilocybin once it receives the license. NaturoMed’s lead scientist is currently working on new extraction processes to create medicinal IP.
Similar Posts
Can DMT Treat Depression?
Welcome to the Psychedelic Spotlight podcast. In this episode, the Psychedelic Investor sits down with Dr. Carol Routledge, Chief Scientific and Chief Medical Officer of Small Pharma (TSX.V: DMT, OTC: DMTTF). Dr. Carol Routhledge is an expert in psychedelic medicines, and she specializes in DMT.
In this interview, we attempted to answer the following questions:
What happens when you take DMT?
Can DMT help with depression?
Is DMT safe?
Small Pharma is a company that I am very excited about, as they are focussing on the psychedelic DMT, which I believe to have unlimited potential as a mental health drug.
Small Pharma is currently running a phase 2 Clinical Trial Attempting to treat Major Depressive Disorder using DMT, the world’s furthest progress DMT Study. We can expect results by the end of the year. If they are successful, the company will begin a phase 3 trial.
#DMT #SmallPharma #depression
Military: Cold War Psychedelics Experiments
Explore the fascinating intersection of military strategy and psychedelic science during the Cold War era.
Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy Trial
Chief Medical Officer Dr. Guy Goodwin clarifies “COMP360 psilocybin therapy was generally well-tolerated” by patients with treatment-resistant depression, despite some adverse reactions from subjects in the study.
Can Psychedelics like MDMA Cure Eating Disorders?
Anyone who has ever suffered from an eating disorder, such…
How Psychedelics Can Transform Your Sex Life
High, drunk, or sober, what’s your favorite way to have…
80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.
New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.